trending Market Intelligence /marketintelligence/en/news-insights/trending/ZiX4NVSuOKr7vw9nmbKdVQ2 content esgSubNav
In This List

Mérieux Equity invests in French pharmaceutical laboratory Addmedica

Blog

Insight Weekly: US election scenarios; borrowing costs rise; commercial REIT fears

Podcast

Street Talk | Episode 100 - KBW CEO offers optimism for bears fearful of bank liquidity, credit

Blog

Insight Weekly: Stocks endure more pain; bank branch M&A slows; debt ratios fall

Blog

Insight Weekly: Unease roils markets; US likely to slip into recession; firms' cash ratios fall


Mérieux Equity invests in French pharmaceutical laboratory Addmedica

Mérieux Equity Partners SAS made an investment in French pharmaceutical laboratory Addmedica SAS through its Mérieux Participations 3 SLP fund.

The private equity firm became the reference shareholder of the company in partnership with founders François Anger and Bernard Dauvergne.

Addmedica develops and markets medicinal products and medical devices for rare diseases, including a benchmark treatment for inherited blood disorder sickle cell disease. The company will use the capital to expand its global footprint and product portfolio.

Duteil et Associés Law Firm and Advance Capital provided support to Mérieux Equity.